INTERFACE PHARMACEUTICALS PVT. LTD. - An ISO 9001:2015 (QMS) & WHO GMP, HACCP, ISO 22000:2005 (FSMS) Certified Company, has more than 27 years of experience in providing true immunomodulators and immunity enhancers. We started with a vision to check antibiotics abuse in poultry & livestock, and to provide world class meat to everyone. In due course we have come out with number of research based products - PROTOFACE, INTERMUNE, PROTOMUNE, NUTRIGROW, CALFACE, GROWFAST-P, MULTIMUNE, READYMUNE are a few of them. In present scenario of frequent viral & bacterial problems, our products have shown their worth and are giving best of the results to provide highest standards of productivity as prescribed by the breed (breeder, broiler or layer). Our products are well accepted against Chicken Anemia Virus (CAV), New Castle Disease Virus (ND), Infectious Bursal Disease (IBD), Inclusion Body Hepatitis (IBH), H9N2, H5N1, H5N8 etc. All the products can be used in any type of disease (Microbial or Viral).
| Website | http://www.interfacepharma.com |
| Revenue | $5.8 million |
| Employees | 24 (14 on RocketReach) |
| Founded | 1999 |
| Phone | +91 11 2512 0024 |
| Technologies |
JavaScript
,
jQuery
,
ASP.NET
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Web Rank | 19 Million |
| Keywords | Pharmaceutical Manufacturing, Immunomodulators, Drug Manufacturer, Healthcare, Biotechnology, Medicine Manufacturer, Quality Management Systems, Who Gmp Certified, Haccp Certified, Iso 22000 Certified, Iso 9001 Certified, Nutraceuticals, Health Supplements, Immunology, Drug Development, Pharmaceutical Products, Clinical Trials, Regulatory Affairs |
| Competitors | Amgen, Biogen, Lilly India, Roche, Pfizer, Novartis, Gilead Sciences, Merck & Co., Inc., Bristol Myers Squibb, Regeneron +47 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Interface Pharmaceuticals Pvt. Ltd. employee's phone or email?
The Interface Pharmaceuticals Pvt. Ltd. annual revenue was $5.8 million in 2026.
Manan Malhotra is the Executive Director of Interface Pharmaceuticals Pvt. Ltd..
14 people are employed at Interface Pharmaceuticals Pvt. Ltd..
Interface Pharmaceuticals Pvt. Ltd. is based in New Delhi, Delhi.
The NAICS codes for Interface Pharmaceuticals Pvt. Ltd. are [3254, 32, 32541, 325].
The SIC codes for Interface Pharmaceuticals Pvt. Ltd. are [283, 28].